Submit Your Feeds

Business News • MarketWire • Lpath, the Category Leader of Lipidomics-Based Therapeutics, Provides Status Update and Outlines Near-Term Goals

Lpath, the Category Leader of Lipidomics-Based Therapeutics, Provides Status Update and Outlines Near-Term Goals

Lpath, the Category Leader of Lipidomics-Based Therapeutics, Provides Status Update and Outlines Near-Term Goals

Teleconference Call Scheduled for Today at 1:00 p.m. ET

View More : http://www.marketwire.com/mw/release.do?id=1300542&sourceType=3

Releted News by marketwire

Lpath, the Category Leader of Lipidomics-Based Therapeutics, Provides Status Update and Outlines Near-Term Goals

ERF Wireless Confirms All Outstanding Convertible Debt Now Paid in Full